Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Prepaid Assets (2016 - 2025)

Plus Therapeutics has reported Prepaid Assets over the past 16 years, most recently at $1.7 million for Q4 2025.

  • Quarterly Prepaid Assets rose 210.2% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, up 210.2% year-over-year, with the annual reading at $1.7 million for FY2025, 210.2% up from the prior year.
  • Prepaid Assets was $1.7 million for Q4 2025 at Plus Therapeutics, up from $985000.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $3.0 million in Q4 2022 and troughed at $406000.0 in Q1 2025.
  • The 5-year median for Prepaid Assets is $852500.0 (2021), against an average of $962250.0.
  • Year-over-year, Prepaid Assets plummeted 86.33% in 2023 and then soared 210.2% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $1.3 million in 2021, then skyrocketed by 126.51% to $3.0 million in 2022, then plummeted by 86.33% to $410000.0 in 2023, then skyrocketed by 36.34% to $559000.0 in 2024, then soared by 210.2% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Prepaid Assets are $1.7 million (Q4 2025), $985000.0 (Q3 2025), and $1.3 million (Q2 2025).